Covid-19 roundup: FDA grants pri­or­i­ty re­view to Roche's Actem­ra; WHO sus­pends UN sup­ply of Co­v­ax­in — re­port

4 years ago
Coronavirus

Run­ning be­hind Bris­tol My­ers and J&J, Bay­er inch­es for­ward in the next-gen blood thin­ner race

4 years ago
R&D

Al­ny­lam's po­ten­tial fourth RNAi ap­proval de­layed three months, but im­pact like­ly to be 'mod­est'

4 years ago
R&D
Pharma

'Rapid' path for Curis' lead leukemia drug hits road­block with par­tial clin­i­cal hold af­ter pa­tient death

4 years ago
R&D
Pharma

The good, the bad and lots of just plain old ug­ly: The Q1 num­bers are in

4 years ago

Sanofi taps out­siders for new board to check its home­work on di­ver­si­ty, eq­ui­ty and in­clu­sion

4 years ago
Pharma
Marketing

Cross-cul­tur­al study finds health tech and ad­ver­tis­ing pop­u­lar with His­pan­ic com­mu­ni­ty, amid gen­er­a­tional shifts

4 years ago
Pharma
Marketing

Chirps, chats and Club­hous­es: First-time biotech founders turn to so­cial me­dia for ad­vice, in­vestors and re­cruit­ment

4 years ago
Startups
In Focus

Bris­tol My­ers touts up­beat da­ta for its block­buster heart drug can­di­date

4 years ago
R&D

FDA cuts off use of GSK's Covid treat­ment in al­most half of the US as BA.2 spreads

4 years ago
Coronavirus

No­var­tis CEO Vas Narasimhan re­struc­tures the phar­ma gi­ant, cut­ting costs $1B+, oust­ing top ex­ecs and sig­nal­ing ...

4 years ago
Pharma

A Penn spin­out goes dark; Thumbs down on ALS drug; TIG­IT runs in­to PhI­II flop; Sanofi's got big plans; and more

4 years ago
Weekly

Sage touts pos­i­tive ear­ly sig­nals in Alzheimer's. Will they be able to re­peat it in a blind­ed study?

4 years ago
R&D
Pharma

Scoop: A Penn Parkin­son's spin­out goes dark as ex-FDA com­mish Hahn jumps off board

4 years ago
Startups

Mid­dle of the road for CEOs: Bris­tol My­er­s' Gio­van­ni Caforio se­cured al­most $20M in 2021 com­pen­sa­tion

4 years ago
People
Pharma

Har­vard sci­en­tist Charles Lieber seeks ac­quit­tal in 'ill-con­ceived' Chi­na Ini­tia­tive case

4 years ago
People
China

On­tario antes up $580M for C&G ther­a­py plant in Hamil­ton

4 years ago
Pharma
Manufacturing

In Lil­ly so­cial me­dia video se­ries, em­ploy­ees open up about Alzheimer's per­son­al ties — and in­spi­ra­tion

4 years ago
Pharma
Marketing

More biosim­i­lar use could've saved Medicare and ben­e­fi­cia­ries $84M in 2019, HHS OIG says

4 years ago
FDA+

Seagen CEO Clay Sie­gall hauls in more than most Eu­ro­pean coun­ter­parts and Mod­er­na's Ban­cel

4 years ago
People
Pharma

Sanofi's plan to list its API spin­out in France is a go

4 years ago
Pharma
Manufacturing

Mer­ck­'s pneu­mo­coc­cal vac­cine suf­fers PDU­FA de­lay in pe­di­atric pop­u­la­tion, with Pfiz­er hot on its tail

4 years ago
R&D
FDA+

Covid-19 roundup: Con­gress re­port­ed­ly near­ing $10B fund­ing deal; Mer­ck and Ridge­back tout new mol­nupi­ravir da­ta

4 years ago
Coronavirus

Most Chi­nese firms could keep their US list­ings un­der draft frame­work — re­port

4 years ago
China
Pharma
First page Previous page 546547548549550551552 Next page Last page
A service from the Financial Times